Seattle Genetics Financial Statements Trends

SGEN -- USA Stock  

USD 70.52  2.49  3.66%

This module enables investors to look at Seattle Genetics various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Seattle Genetics Valuation or Volatility. It can also complement various Seattle Genetics Technical models. Also please take a look at analysis of Seattle Genetics Correlation with competitors.

Cash and Equivalents Analysis

Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Seattle Genetics 
Cash 
 = 
Bank Deposits 
+  
Liquidities 
 = 
399.92 M

About Cash and Equivalents

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).
Compare to competition
In accordance with recently published financial statements Seattle Genetics has 399.92 M in Cash and Equivalents. This is 54.04% lower than that of the Healthcare sector, and 55.88% lower than that of Biotechnology industry, The Cash and Equivalents for all stocks is 89.72% higher than the company.

Seattle Genetics Fundamental Drivers Relationships

Seattle Genetics is rated fourth in shares owned by institutions category among related companies. It is rated below average in return on equity category among related companies .

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Seattle Genetics Upcoming Company Events

Upcoming Quarterly ReportApril 27, 2017
Next Earnings ReportJuly 25, 2017
Also please take a look at analysis of Seattle Genetics Correlation with competitors. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">